Sui Xiong Cai - IMPACT Therapeut Inc

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 18 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Discovery of a Potent PARP1 Inhibitor Senaparib

Sui Xiong Cai, Ning Ma,Xiaozhu Wang,Mingchuan Guo,Yangzhen Jiang, Ye E Tian

Molecular cancer therapeutics (2024)

引用0浏览0WOS引用

Discovery and development of a potent and highly selective WEE1 inhibitor IMP7068

Sui Xiong Cai, Ning Ma,Xiaozhu Wang,Yangzhen Jiang, Hongxia Zhang,Mingchuan Guo,Ruiyu Zhou,Ye Edward Tian

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

Safety, Tolerability, and Pharmacokinetics of Senaparib, a Novel PARP1/2 Inhibitor, in Chinese Patients With Advanced Solid Tumors: A Phase I Trial

Junning Cao,Hongqian Guo,Dongmei Ji,Weina Shen,Shun Zhang,Chih-Yi Hsieh,Sui Xiong Cai,Ye Edward Tian,Cong Xu,Pin Zhang,Binghe Xu

The oncologistno. 12 (2023): e1259-e1267

引用0浏览0WOS引用

Effect of a Strong CYP3A4 Inhibitor and Inducer on the Pharmacokinetics of Senaparib (IMP4297) in Healthy Volunteers: A Drug-Drug Interaction Study

Xiaolei Hu,Chih-Yi Hsieh,Yanxin Zhang,Wanli Liu,Sumei Xu,Sui Xiong Cai,Lan Liu,Ming Zhang,Huiyan Shi,Hongxia Zhang,Ping Liu, Xiaomin Li,Pingsheng Xu

BJCP British journal of clinical pharmacology/British journal of clinical pharmacology（2023）

引用1浏览0WOS引用

Abstract 3091: Discovery and Development of a Potent and Highly Selective WEE1 Inhibitor IMP7068

Sui Xiong Cai, Ning Ma, Xu Wang,Yangzhen Jiang, Hongxia Zhang,Mingchuan Guo,Ruiyu Zhou, Ye Tian

Cancer researchno. 7_Supplement (2023): 3091-3091

引用0浏览0引用

Abstract 1399: Discovery and Development of PARP Inhibitor Senaparib

Sui Xiong Cai, Ning Ma,Xiaozhu Wang,Yangzhen Jiang,Mingchuan Guo,Chih-Yi Hsieh,Ye Edward Tian

Cancer researchno. 12_Supplement (2022): 1399-1399

引用0浏览0引用

Discovery and development of PARP inhibitor senaparib

Sui Xiong Cai, Ning Ma,Xiaozhu Wang,Yangzhen Jiang,Mingchuan Guo,Chih-Yi Hsieh,Ye Edward Tian

CANCER RESEARCHno. 12 (2022)

引用0浏览0引用

A phase 1 dose-escalation and -expansion study of IMP7068, a WEE1 inhibitor, in patients with advanced solid tumors

Chia-Chi Lin,Jaspreet Singh Grewal,David Sommerhalder,James Fredric Strauss,Li-Yuan Bai,Lin Shen,Yu-Min Yeh,Chih-Yi Hsieh,Sui Xiong Cai,Ye Edward Tian, Huan Xia,Congcong Zhang,Baoyue Li,Ming Zhang, Ning Ma, Liping Zhao, Jie Ma,Huiyan Shi, Zhixin Yu

Journal of Clinical Oncology（2022）

引用2浏览0引用

A study of senaparib in combination with temozolomide for the treatment of patients with advanced solid tumors and extensive-stage small cell lung cancer

Bo Gao,Chia-Chi Lin,Li-Yuan Bai,Wei-Pang Chung,Wan-Chen Kao,Robert Zielinski,Byoung Yong Shim,Min Hee Hong,Sang-We Kim,Chien-Ying Liu,Chih-Yi Hsieh,Sui Xiong Cai,Ye Edward Tian, Lan Liu, Tiantian Niu, Clare Halcro,Baoyue Li, Ning Ma,Congcong Zhang, Xiangna Chen

Journal of Clinical Oncology（2022）

引用0浏览0引用

Combination of senaparib with temozolomide for the treatment of cancer

Sui Xiong Cai, Ning Ma,Xiaozhu Wang, Jie Ma,Mingchuan Guo,Ruiyu Zhou, Lan Liu,Chih-Yi Hsieh,Ye Edward Tian

CANCER RESEARCHno. 12 (2022)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn